Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus α-toxin
Authors:
- Ulf SibeliusUSUlf Sibelius
- Jan SchrickelJSJan Schrickel
- Detlef SchmidtDSDetlef Schmidt
- Michael BuerkeMBMichael Buerke
- Ludger FinkLFLudger Fink
- Emmanoyil BournelisEBEmmanoyil Bournelis
- Martina HeepMHMartina Heep
- Konstantin MayerKMKonstantin Mayer
- Rainer M. BohleRBRainer M. Bohle
- Werner SeegerWSWerner Seeger
- Friedrich GrimmingerFGFriedrich Grimminger
- 1 January 2001
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 29 (1) , 1-7
Abstract
Myocardial depression, which frequently occurs in the course of septic shock, has been attributed to the cardiodepressant properties of nitric oxide (NO) generated by either the inducible NO synthase (iNOS) or the constitutive isoform (cNOS). We have previously demonstrated that alpha-toxin from Staphylococcus aureus induces thromboxane-mediated vasoconstriction accompanied by severe cardiodepression in isolated rat hearts. In the present study, we investigated the role of NO in the alpha-toxin-induced vascular and contractile abnormalities. Prospective, experimental study. Research laboratory at a university hospital. Isolated hearts from male Wistar rats. Isolated hearts were perfused with purified staphylococcal alpha-toxin for 60 mins. At a concentration of 0.25 and 0.5 microg/mL, alpha-toxin induced a rise in coronary perfusion pressure, depressed myocardial contractility, and caused edema formation. Simultaneously, a time- and dose-dependent rapid release of NO into the perfusate was noted as quantified by a chemiluminescence technique. L-NMMA, a nonselective inhibitor of NOS, but not PBITU, an iNOS-selective inhibitor, blocked NO synthesis, markedly increased the rise in coronary perfusion pressure and the loss in contractility, and enhanced edema formation in response to alpha-toxin. In contrast, zaprinast, a selective inhibitor of phosphodiesterase type V that is used for stabilization of cyclic guanosine monophosphate, attenuated the toxin-induced coronary vasoconstrictor response and the myocardial depression. L-arginine, the substrate of NOS, had similar, yet less potent, effects as zaprinast and slightly increased the release of NO caused by alpha-toxin. Immunohistochemical analysis of the myocardium at the end of the perfusion period demonstrated a positive staining for cNOS but not for iNOS. In addition, no up-regulation of iNOS mRNA was detected in the tissue of toxin-exposed hearts. Staphylococcal alpha-toxin provokes NO biosynthesis via activation of cNOS in rat hearts. NO partly antagonizes the deleterious effects of this pathogenicity factor on coronary vasoregulation and myocardial performance.Keywords
This publication has 41 references indexed in Scilit:
- Effects of tumour necrosis factor‐α on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac functionBritish Journal of Pharmacology, 1999
- Effects of tumour necrosis factor‐α on the coronary circulation of the rat isolated perfused heart: a potential role for thromboxane A2 and sphingosineBritish Journal of Pharmacology, 1998
- Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.Journal of Experimental Medicine, 1996
- Septic Shock in HumansAnnals of Internal Medicine, 1990
- Right Ventricular Dysfunction and Dilatation, Similar to Left Ventricular Changes, Characterize the Cardiac Depression of Septic Shock in HumansChest, 1990
- Responses of left ventricular function in survivors and nonsurvivors of septic shockJournal of Critical Care, 1989
- Right ventricular dysfunction in septic shock: assessment by measurements of right ventricular ejection fraction using the thermodilution techniqueActa Anaesthesiologica Scandinavica, 1989
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.Journal of Clinical Investigation, 1985
- Two-dimensional echocardiographic demonstration of acute myocardial depression in septic shockCritical Care Medicine, 1984
- Profound but Reversible Myocardial Depression in Patients with Septic ShockAnnals of Internal Medicine, 1984